Zafemy Patch
Product Images NDC 72162-2220

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Zafemy (NDC 72162-2220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622220)

This text appears to be a description of a transdermal contraceptive patch containing norelgestromin and ethinyl estradiol. Each 12.5 cm² patch contains 3.15 mg of norelgestromin and 0.289 mg of ethinyl estradiol. The product is intended for transdermal use only and should be kept out of reach of children. It should not be stored unpouched and should be stored at a temperature of 20°-25°C (77°F). The patch is intended to be worn for 7 days as prescribed to prevent pregnancy. It does not protect against HIV infection or other sexually transmitted diseases.*

FDA Label Image

Where To Put Patch (Zafemy Norelgestromin And Ethinyl Estradiol Transd 1)

FDA Label Image

Figure 4 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 10)

FDA Label Image

Figure 5 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 11)

FDA Label Image

Figure 6 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 12)

FDA Label Image

01 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 13)

FDA Label Image

02 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 14)

FDA Label Image

03 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 15)

FDA Label Image

Figure A (Zafemy Norelgestromin And Ethinyl Estradiol Transd 16)

FDA Label Image

Figure B (Zafemy Norelgestromin And Ethinyl Estradiol Transd 17)

FDA Label Image

Where To Put Patch (Zafemy Norelgestromin And Ethinyl Estradiol Transd 18)

FDA Label Image

Usage Illustration 1 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 19)

FDA Label Image

Usage Illustration 1 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 2)

FDA Label Image

Usage Illustration 2 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 20)

FDA Label Image

Usage Illustration 3 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 21)

FDA Label Image

Usage Illustration 4 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 22)

FDA Label Image

Usage Illustration 2 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 3)

FDA Label Image

Usage Illustration 3 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 4)

FDA Label Image

Usage Illustration 4 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 5)

FDA Label Image

Figure 2 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 6)

FDA Label Image

1 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 7)

FDA Label Image

Structural Formula (Zafemy Norelgestromin And Ethinyl Estradiol Transd 8)

FDA Label Image

Figure 3 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 9)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.